Nuago Therapeutics Inc.

Chicago, IL

UEI
EAFACY3U2AZ2
CAGE
9EZG5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1901 S Calumet Ave, Chicago, IL 60616, USA
Website
nuagotherapeutics.com
Founded
2020
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nuago Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of a dise-inducing, short RNA therapeutic to treat ovarian cancer - project summary existing targeted cancer… Grant · R42CA291346 National Cancer Institute $400,000
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer - project summary prostate cancer… Grant · R41CA287846 National Cancer Institute $400,000

Quick answers

What is Nuago Therapeutics Inc.'s UEI?

Nuago Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is EAFACY3U2AZ2.

What is Nuago Therapeutics Inc.'s CAGE code?

Nuago Therapeutics Inc.'s CAGE code is 9EZG5.

What is Nuago Therapeutics Inc.'s primary NAICS code?

Nuago Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Nuago Therapeutics Inc. located?

Nuago Therapeutics Inc.'s physical address in SAM.gov is 1901 S Calumet Ave, Chicago, IL 60616, USA.

Is Nuago Therapeutics Inc. registered in SAM.gov?

Yes. Nuago Therapeutics Inc.'s SAM.gov registration is active through July 8, 2027.

What is Nuago Therapeutics Inc.'s most recent federal award?

Nuago Therapeutics Inc.'s most recent federal grant award is Development of a dise-inducing, short RNA therapeutic to treat ovarian cancer - project summary existing targeted cancer… (R42CA291346), from National Cancer Institute, on June 9, 2025.

On GovTribe

See Nuago Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login